Fabrice Egros serves as Executive at Syndax Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Fabrice Egros has executed 16 insider transactions totaling $1.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 2, 2022 involved receiving (via award) 16,000 shares valued at $0.
Fabrice Egros currently holds 32,000 shares of Syndax Pharmaceuticals Inc (SNDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fabrice Egros has been a net seller of SNDX stock. They have purchased $0 and sold $1.0M worth of shares.
Fabrice Egros's most recent insider trade was on Feb 2, 2022, when they sold 16,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.93 |
| Discretionary |
| Nov 18, 2021 | SNDX | $236 | Option Exercise | 30 | $7.88 | Discretionary |
| Nov 18, 2021 | SNDX | $541 | Sale | 30 | $18.03 | Discretionary |
| Nov 18, 2021 | SNDX | $252.4K | Sale | 14,000 | $18.03 | Discretionary |
| Aug 18, 2021 | SNDX | $123.2K | Option Exercise | 15,635 | $7.88 | Discretionary |
| Aug 18, 2021 | SNDX | $246.3K | Sale | 15,635 | $15.75 | Discretionary |
| May 18, 2021 | SNDX | $31.4K | Sale | 1,683 | $18.65 | Discretionary |
| May 18, 2021 | SNDX | $222.4K | Sale | 11,926 | $18.65 | Discretionary |
| May 18, 2021 | SNDX | $13.3K | Option Exercise | 1,683 | $7.88 | Discretionary |
| May 18, 2021 | SNDX | $85.9K | Option Exercise | 11,926 | $7.20 | Discretionary |
| Mar 1, 2021 | SNDX | $64.6K | Option Exercise | 10,167 | $6.35 | Discretionary |
| Mar 1, 2021 | SNDX | $247.2K | Sale | 10,167 | $24.31 | Discretionary |
| Mar 1, 2021 | SNDX | $1.8K | Sale | 74 | $24.31 | Discretionary |
| Mar 1, 2021 | SNDX | $533 | Option Exercise | 74 | $7.20 | Discretionary |
| Feb 3, 2021 | SNDX | $0 | Award | 16,000 | $N/A | Discretionary |